SCHEMBL7987598

SCHEMBL7987598

CCC(=O)Nc1ncn(Cc2ccc3ccccc3c2)c1C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIOK2 Q9BVS4 4/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.40
ICMT O60725 3/20 0.40
GSK3A P49840 3/20 0.39
MAPK10 P53779 3/20 0.39
MAPK8 P45983 1/20 0.39
HIPK1 Q86Z02 1/20 0.39
SNRK Q9NRH2 1/20 0.39
FGFR1 P11362 1/20 0.39
FGFR4 P22455 1/20 0.39
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MC4R P32245 1/20 0.38
MC5R P33032 1/20 0.38
JAK3 P52333 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991565 0.86 TSHR (0.49) KMT2AFGFR1FGFR4KDM4EHPGD
SCHEMBL7988641 0.84 KMT2A (0.44) KMT2AMEN1GSK3AFGFR1FGFR4
SCHEMBL7987961 0.83 MAPT (0.47) KMT2AMAPK8ALDH1A1YTHDC1
SCHEMBL7992368 0.83 TP53 (0.47) KMT2AMEN1MAPK8RAB9AYTHDC1
SCHEMBL7973987 0.83 FGFR1 (0.45) KMT2AFGFR1FGFR4RAB9ASMN1; SMN2
SCHEMBL7985508 0.83 ALDH1A1 (0.43) KMT2AMEN1MAPK10L3MBTL1ALDH1A1
SCHEMBL7974162 0.83 KDM4E (0.52) KMT2AFGFR1FGFR4KDM4EL3MBTL1
SCHEMBL7985670 0.83 CDK9 (0.42) KMT2AMAPK8KDM4EL3MBTL1ALDH1A1
SCHEMBL7974223 0.82 RAB9A (0.46) RAB9AL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL7986281 0.81 KMT2A (0.39) KMT2AFGFR1FGFR4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed